Follow The Filings

BIVI BioVie

BioVie earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by BIVI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BIVI insider trades
  • $49K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Joseph M Palumbo Chief Medical Officer
    Buy
    $10K 4,843 shares at $2.16 +406% to stake
    Traded Aug 28 Filed Aug 28
    ↗
  2. Amy Suzon Chappell Director
    Buy
    $1,570 727 shares at $2.16 New stake
    Traded Aug 28 Filed Aug 28
    ↗
  3. Joanne Wendy Kim CFO
    Buy
    $5,450 2,500 shares at $2.18 +266% to stake
    Traded Aug 28 Filed Aug 28
    ↗
  4. Cuong V Do CEO
    Buy
    $32K 15,210 shares at $2.08 +1677% to stake
    Traded Aug 27 Filed Aug 28
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
S-1/A FORM S-1 AMENDMENT NO.3 Filing Doc
10-K FORM 10-K FOR PERIOD ENDED JUNE 30, 2026 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
S-1/A FORM S-1 AMENDMENT NO. 2 Filing Doc
S-1/A FORM S-1 AMENDMENT NO. 1 Filing Doc
S-1 FORM S-1 REGISTRATION STATEMENT Filing Doc
10-Q FORM 10-Q FOR PERIOD ENDING MARCH 31, 2026 Filing Doc
SCHEDULE 13D — Filing Doc
10-Q FORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2025 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2025 Filing Doc
424B3 424B3 PROSPECTUS SUPPLEMENT NO.1 Filing Doc
DEF 14A Filing Doc
10-K FORM 10-K Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
424B5 Filing Doc
S-1/A FORM S-1 AMENDMENT NO. 3 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.